KNKaouther Nesba

Kaouther Nesba

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kaouther Nesba has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    EVALUATION OF FERROCENYLMETHYLNUCLEOBASES DERIVATIVES INTERACTING WITH DNA: INSIGHTS FROM ELECTROCHEMICAL, SPECTROSCOPIC, DFT CALCULATION, MOLECULAR DOCKING AND MOLECULAR DYNAMIC SIMULATIONS

    by Mohammed Larbi Ben Amor, Elhafnaoui Lanez, Yahia Bekkar, Aicha Adaika, Touhami Lanez, Kaouther Nesba, Lazhar Bechki

    This study investigates the binding of ferrocenylmethyl nucleobase derivatives to DNA through electrostatic interactions, employing a combination of experimental and theoretical approaches to elucidate binding mechanisms and explore their potential for DNA targeting. UV–Vis spectroscopy and cyclic voltammetry (CV) were used to evaluate binding affinities and structural alterations in DNA. The derivatives exhibited DNA interactions, evidenced by negative formal potential shifts in CV data. Binding constants and free binding energies derived from docking simulations aligned well with UV–Vis and CV analyses. Additionally, voltammetric data provided insights into the binding site size. Molecular docking simulations confirmed the critical role of electrostatic interactions in the binding of FcMeCy, FcMeTh, and (FcMe)2Ad to DNA. Molecular dynamics simulations further revealed the stability of DNA-ligand complexes, with RMSD and radius of gyration (Rg) analyses indicating compact and stable DNA structures, emphasizing the robustness of these interactions for therapeutic applications. Theoretical investigations, including geometry optimization, Mulliken charge distribution, molecular electrostatic potential (MEP) analysis, and HOMO-LUMO surface analysis using density functional theory (B3LYP/aug-cc-pVTZ/6-311++G(d,p)), offered deeper insights into structural properties, reactive sites, and chemical reactivity. These results provide a comprehensive understanding of the interaction mechanisms and potential applications of these derivatives.


  • Exploring the Interactions of Ferrocenylmethylnucleobase Derivatives With BSA and HHb: Insights From Electrochemical, Spectroscopic, ADMET, in Silico Docking, and MD Simulations

    by Mohammed Larbi BEN Amor, Elhafnaoui Lanez, Yahia Bekkar, Aicha Adaika, Touhami Lanez, Kaouther Nesba, Lazhar Bechki

    The present study has investigated the binding interactions of four N‐ferrocenylmethyl‐nucleobase derivatives: N1‐ferrocenylmethyladenine (FcMeAd), N1‐ferrocenylmethyl‐cytosine (FcMeCy), N1‐ferrocenylmethylthymine (FcMeTh), and N6,9‐bis(ferrocenyl‐methyl)adenine ((FcMe) 2 Ad), with human hemoglobin (HHb) and bovine serum albumin (BSA). A combination of absorption spectroscopy, cyclic voltammetry, molecular docking, and molecular dynamics simulations is employed to investigate these interactions. The obtained results demonstrated that these derivatives can bind to the target proteins, inducing conformational changes with the binding affinity order: FcMeCy > FcMeTh > FcMeAd > (FcMe) 2 Ad. Molecular docking studies identified the preferred binding sites and modes, revealing that hydrogen and hydrophobic predominantly facilitate the binding to BSA and HHb, also exhibiting π–π stacking interactions with FcMeCy and FcMeAd. Dynamic simulations of the FcMeCy‐BSA and FcMeCy‐HHb complexes, selected based on both experimental and theoretical results, further confirmed their stability within the protein binding pockets. The RMSD, RMSF, rGyr, SASA, H‐bonds, MolSA, and PSA parameters consistently indicated that FcMeCy maintains stability in the receptor binding site throughout the 100 ns simulation.


  • Synthesis, Antioxidant, and Antidiabetic Potential of Ferrocenylmethylnucleobase Compounds: In Vitro, In Silico Molecular Docking, DFT Calculation, and Molecular Dynamic Simulations

    by Aicha Adaika, Yahia Bekkar, Souhir Youmbai, Lotfi Bourougaa, Elhafnaoui Lanez, Mohammed Larbi Ben Amor, Kaouther Nesba, Touhami Lanez, Lazhar Bechki

    This study presents the synthesis and characterization of a novel series of ferrocenylmethylnucleobase compounds, namely, FcMeAd, FcMeCy, FcMeTh, and (FcMe)₂Ad with promising antioxidant and antidiabetic properties. Spectroscopic techniques confirmed their sandwich‐like geometry, with the nucleobase moiety coordinated to the ferrocene unit. Density functional theory (DFT) optimization revealed alignment with existing crystallographic data and indicated low frontier molecular orbital (FMO) energy gaps, suggesting facile intramolecular charge transfer and potential biological activity. The antidiabetic activity was evaluated in vitro through inhibition assays targeting α‐glucosidase and α‐amylase enzymes, which was supported by in silico molecular docking studies. Among the compounds, FcMeTh exhibited the highest antidiabetic and antioxidant properties due to the presence of carbonyl and amide functionalities, along with an electron‐donating methyl group. Molecular dynamics (MD) simulations confirmed high binding affinity and structural stability of the docked compounds, with strong interactions with the target enzymes, further validating the potential of these compounds as effective inhibitors. Pharmacokinetic and ADMET evaluations indicated their nontoxic, noncarcinogenic nature and suitability for oral administration. The combined in vitro and in silico findings, including the critical insights from MD simulations, suggest that these ferrocenylmethylnucleobase compounds, especially FcMeTh, possess enhanced antioxidant and antidiabetic properties. This highlights their potential as promising therapeutic agents for managing oxidative stress and Type 2 diabetes.